Abstract
Author(s): Maged ElShorbagy, Ahmed Sewidan, Hatem El Sahar*, Karim El Etriby
Background: Combined Abdominoplasty-Hysterectomy (ABP-HYS) has streamlined anesthesia, hospital stays, and recovery. Concerns about higher risks have diminished, and selected patients demonstrate safety comparable to separate procedures. Benefits include coordinated care, fewer surgeries, and improved efficiency, though careful patient selection is crucial. Objective of the study: To evaluate the safety and surgical results of combined Abdominoplasty and Hysterectomy (ABP-HYS) in comparison to abdominoplasty performed independently. Patients and method: This retrospective cohort study from a private hospital in Egypt (2015–2019) analyzed adult women undergoing abdominoplasty, with or without total abdominal hysterectomy. Exclusions included incomplete data and unrelated procedures. Primary outcomes were 30-day postoperative morbidity and mortality, including readmissions and reoperations, while secondary outcomes focused on operative time and hemoglobin changes. A total of 250 patients were evaluated: 220 had Abdominoplasty (ABP) alone and 30 had ABP+TAH. No significant differences were found in 30-day complications (18.18% for ABP vs. 13.3% for ABP+TAH, P=0.598) or in unplanned reoperations and infections. However, blood transfusion rates were higher in the ABP+TAH group (80% vs. 11.36%; P<0.0001), and this group experienced longer hospital stays (3 vs. 1 day; P<0.001), increased operative time (228 vs. 148 minutes; P<0.001), and greater hemoglobin decline (2.5 vs. 1.0 g/dL; P<0.001). Logistic regression showed no significant link between ABP+TAH and overall complications (OR 1.05; 95% CI 0.70– 1.57; P=0.598), though operative time and hemoglobin drop were independent predictors of complications. Conclusion: Combined ABP-HYS did not increase 30-day morbidity compared with ABP alone, though it prolonged surgery and hospitalization with greater hemoglobin decline; overall, short-term safety appears comparable